Stem cell therapy could treat Parkinson's

| | Health Imaging | Molecular Imaging

A novel non-embyronic stem cell therapy is being studied to replace damaged dopaminergic brain cells in Parkinson's patients with their own cells in the hopes of restoring normal movement.

The Parkinson's Association of San Diego, Scripps Research Institute and Scripps Clinic have mounted an effort to promote the treatment, which is based on the harvesting of stem cells from patients' skin. A formal application for the treatment will reportedly be filed with the FDA this month.

Parkinson’s stem cell project aims for 2014 approval via San Diego Union-Tribune

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.